Abstract Microplastics (MPs) and nanoplastics (NPs) are emerging environmental pollutants,
having a major ecotoxicological concern to humans and many other biotas, especially …

With excellent physicochemical properties, inorganic nanomaterials (INMs) have exhibited a
series of attractive applications in biomedical fields. Biological barriers prevent successful …

Objectives: To improve preclinical drug testing during pregnancy, we developed multiple
microfluidic organ-on-chip (OOC) devices that represent the structure, functions, and …

Over the past decade, organs-on-a-chip and microphysiological systems have emerged as a
disruptive in vitro technology for biopharmaceutical applications. By enabling new …

The genetic material encoded on X and Y chromosomes provides the foundation by which
biological sex differences are established. Epigenetic regulators expressed on these sex …

Pathologies associated with uteroplacental hypoxia, such as preeclampsia are among the
leading causes of maternal and perinatal morbidity in the world. Its fundamental …

Preterm birth (PTB) is defined as delivery before 37 weeks of gestation. Globally, 15 million
infants are born prematurely, putting these children at an increased risk of mortality and …

Increasing data on the infection indicate that maternal infections are severe. Under the
realms of vaccine development, virus‐like particles (VLP)/nanoparticles (NPs) hold the …

Homeostatic regulation of the maternal milieu during pregnancy is critical for maternal and
fetal health. The placenta facilitates critical communication between maternal and fetal …

Increasing human exposure to nanoparticles (NPs) from various sources raises concerns for
public health, especially for vulnerable risk groups like pregnant women and their …